13 completed, 2 terminated. 9 Phase 2, 3 Not applicable, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 8, Terminated 1 |
| Not applicable | 3 | Completed 2, Terminated 1 |
| Phase 1 | 3 | Completed 3 |
Follow Recurrent Uterine Sarcoma: new trials by email Literature Review of Recurrent Uterine Sarcoma trials Research Report on Recurrent Uterine Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter | Not applicable | Completed | City of Hope Medical Center | 200 | 2013-10-29 | 2026-10-01 |
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer stereotactic body radiation therapy, carboplatin, gemcitabine hydrochloride - Leydig Cell Tumor, Ovarian Sarcoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 12 | 2012-05-01 | 2015-08-04 |
| Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer questionnaire administration, quality-of-life assessment, psychosocial assessment and care - Anxiety Disorder, Depression | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 39 | 2010-10-01 | 2015-10-09 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus temsirolimus - Recurrent Uterine Sarcoma, Uterine Carcinosarcoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 8 | 2010-01-01 | 2016-11-09 |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery therapeutic angiotensin-(1-7), laboratory biomarker analysis - Bone Cancer, Chondrosarcoma | Phase 2 | Completed | Wake Forest University Health Sciences | 20 | 2009-10-01 | 2018-07-05 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma saracatinib - Adult Fibrosarcoma, Adult Leiomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2008-02-01 | 2018-06-29 |
| Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus sunitinib malate - Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 44 | 2006-10-01 | 2019-07-23 |
| Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma ziv-aflibercept - Fallopian Tube Cancer, Female Reproductive Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 63 | 2006-09-01 | 2015-12-07 |
| Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma sorafenib tosylate - Adult Angiosarcoma, Adult Epithelioid Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 147 | 2005-09-01 | 2014-05-23 |
| Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer sorafenib tosylate - Recurrent Uterine Sarcoma, Stage III Uterine Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 56 | 2005-02-01 | 2015-11-20 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
| Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer imatinib mesylate, laboratory biomarker analysis - Recurrent Uterine Sarcoma, Uterine Carcinosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 26 | 2004-01-01 | 2019-07-24 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma tanespimycin, pharmacological study - AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 60 | 1999-10-01 | 2013-02-07 |
Carcinoma, Ovarian Epithelial (7) · Fallopian Tube Neoplasms (5) · Sarcoma (5) · Uterine Cervical Neoplasms (5) · Endometrial Neoplasms (4) · Vaginal Neoplasms (3) · Vulvar Neoplasms (3) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Chondrosarcoma (2) · Colonic Neoplasms (2) · Histiocytoma, Malignant Fibrous (2) · Leiomyosarcoma (2) · Leydig Cell Tumor (2)
Neoplasms (11) · Neoplasms by Histologic Type (11) · Neoplasms by Site (9) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Genital Diseases (8) · Genital Diseases, Female (8) · Genital Neoplasms, Female (8) · Neoplasms, Glandular and Epithelial (8) · Urogenital Diseases (8) · Urogenital Neoplasms (8) · Adnexal Diseases (7) · Carcinoma (7) · Endocrine Gland Neoplasms (7) · Endocrine System Diseases (7)
Early Intervention, Educational (2) · Methods (2) · Radiosurgery (2) · Sirolimus (2) · Sorafenib (2) · temsirolimus (2) · Behavior Therapy (1) · Carboplatin (1) · Gemcitabine (1) · Imatinib Mesylate (1) · Pharmacogenomic Testing (1) · Psychiatric Rehabilitation (1) · Sunitinib (1) · Vinorelbine (1) · aflibercept (1)
National Cancer Institute (NCI) (9) · Case Comprehensive Cancer Center (2) · City of Hope Medical Center (1) · Ohio State University Comprehensive Cancer Center (1) · University of Southern California (1) · Wake Forest University Health Sciences (1)
United States (15) · Canada (3)
Agustin Garcia (1) · Amit Oza (1) · Barbara Andersen, PhD (1) · Betty Ferrell (1) · Gini Fleming (1) · Margaret von Mehren (1) · Mark Einstein (1) · Martee Hensley (1) · Ramesh Ramanathan (1) · Robert DeBernardo, MD (1) · Robert Maki (1) · Stephen Michael Hahn (1) · Steven Waggoner, MD (1) · Warner Huh (1) · William Petty (1)
N01CM62203 (3), N01CM62201 (2), U10CA027469 (2), N01CM00038 (1), N01CM62206 (1), N01CM62209 (1), P01CA087971 (1), P30CA008748 (1), P30CA013330 (1), R21CA135005 (1), U01CA099168 (1)